Imidazole-Based Bicyclic Compound Synthesis Scalability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing imidazole-based compounds, particularly SIP lyase inhibitors, are limited in scalability and efficiency for large-scale production, hindering their testing and potential use in treating diseases like rheumatoid arthritis.
Innovation Solution
The development of methods for synthesizing compounds of formula I, involving the reaction of substituted heterocycles with specific reagents under controlled conditions, including the use of solvents and bases, to produce SIP lyase inhibitors suitable for large-scale manufacture.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthesis methods are used, then compound production is achieved, but scalability and efficiency for large-scale production are limited
Solution Approach 1:
The patent modifies reaction parameters including using alternative solvents (acetonitrile, dimethyl carbonate, ethyl methyl carbonate), adjusting temperature ranges (0-25°C for key steps), and changing reagent equivalents to optimize both yield and scalability. These parameter changes enable transition from small-scale to large-scale production while maintaining efficiency
Solution Approach 2:
The patent employs solid-supported reagents and phase-transfer catalysts that function as porous materials, enabling easier filtration and product isolation. This approach simplifies manufacturing operations and improves scalability by facilitating straightforward separation of products from reaction mixtures
2Quantity of substance
If existing synthesis routes are applied, then imidazole-based compounds are produced, but additional testing and development time is required
Solution Approach 1:
The patent performs preliminary optimization of reaction conditions, purification protocols, and characterization methods during the development phase. By establishing robust standardized procedures in advance, the methodology enables rapid scaling up without requiring additional testing iterations, thus reducing development time
Solution Approach 2:
The synthesis methodology is designed with continuous operation in mind, using reaction conditions and workup procedures that can be maintained continuously rather than requiring repeated start-stop cycles. This continuity reduces overall development time and accelerates compound availability for testing
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the efficient large-scale production of SIP lyase inhibitors, facilitating their testing and potential therapeutic applications, particularly in treating rheumatoid arthritis.
Implementation Method 1
a) combining isoxazole-3-carbonitrile with a solvent and sodium hydroxide to provide a first reaction mixture; b) combining the first reaction mixture with fructosamine
Data Source
AI summary
Methods of preparing compounds of formula I are disclosed: